Latest Innovation News

Straker Ltd reports a solid first half of FY26 with positive EBITDA and a renewed IBM partnership, despite a 15% revenue decline amid challenging market conditions.

Temple & Webster Group delivered a robust FY25 with 21% revenue growth and expanded into New Zealand, reaffirming its ambitious growth and profitability targets for FY26.

Cleo Diagnostics has secured a $1.7 million R&D tax refund, strengthening its cash reserves to $5.75 million as it advances toward a pivotal US clinical trial and FDA submission for its ovarian cancer test.

HyTerra Limited has partnered with GeoKiln Energy Innovation to pioneer a groundbreaking test of engineered geologic hydrogen production, aiming to accelerate commercialization in this emerging energy sector.

Parkway Corporate Limited has marked its transition to profitability in FY25, unveiling a transformative Queensland Brine Management Complex project set to redefine waste brine processing in Australia’s coal seam gas sector.

Genesis Energy’s 2025 Investor Day confirms its strategy and earnings growth remain firmly on track, anchored by a substantial renewable pipeline and robust capital management.

Fisher & Paykel Healthcare reported a robust 14% revenue increase and a 39% jump in net profit for the first half of fiscal 2026, driven by strong clinical adoption and product innovation.

Osteopore Limited has drawn an additional A$250,000 under the first tranche of its redeemable convertible notes, continuing its steady capital raise to support growth and innovation.

Locate Technologies has successfully raised NZ$1 million to bolster its balance sheet ahead of its planned listing on the New Zealand Exchange this December. The capital raise reflects strong investor confidence as the company prepares to transition its logistics technology platform to a new market.

Locate Technologies moves closer to shifting its listing from the ASX to the New Zealand Exchange, completing a NZ$1 million share offer as part of its capital restructure.

Zelira Therapeutics has received a $1.07 million cash refund under Australia’s R&D Tax Incentive Scheme, reinforcing its funding for ongoing clinical trials and product development. The company has also repaid a prior loan advanced against this claim, positioning it for continued growth in cannabinoid-based medicines.

Macquarie Technology Group unveiled ambitious plans to expand its AI-optimised data centre footprint, supported by a $450 million debt facility and strong growth across its cloud, government cybersecurity, and telecom divisions.